China's Bright Food denies interst in British cereal maker Weetabix

23 Apr 2012

1

British cereal maker, Weetabix may change hands with a Chinese state-backed food company eyeing the brand.

However, Bright Food Group Co, China's second-largest food company, has denied the reports that it is in talks to buy British cereals maker Weetabix Ltd from private equity firm Lion Capital, Bloomberg reported quoting a company spkesperson.

Bright Food has been in negotiations for several weeks with Lion Capital, owner of Weetabix, about a possible purchase, which would value British firm at around 1 billion the Telegraph and The Sunday Times reported.

Weetabix can trace its history back to 1932. It has been family-owned until its takeover by Texan private equity firm, Hicks, Muse, Tate and Furst in 2004 for £642 million.

Analysts say Bright Food has placed a value of around £1 billion on the Northamptonshire-based business.

The British brand has a presence across 80 countries, employs around 2,000 people and generates annual sales of £423 million.

Latest articles

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

AI startup Reflection signs over $1 billion computing deal with Nebius

AI startup Reflection signs over $1 billion computing deal with Nebius

Tata Power explores $450 million overseas loan for business operations

Tata Power explores $450 million overseas loan for business operations

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

South Korean firms unveil $195 billion investment in AI and advanced industries

South Korean firms unveil $195 billion investment in AI and advanced industries

HCLTech wins $1.14 billion AI transformation deal with European client

HCLTech wins $1.14 billion AI transformation deal with European client

Microsoft launches Frontier to help enterprises accelerate AI adoption

Microsoft launches Frontier to help enterprises accelerate AI adoption

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs
View details about the software product Informachine File Manager
View details about the software product Informachine News Trackers